EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association Between Active DNA Demethylation and Liver Fibrosis in Individuals with Metabolic-Associated Steatotic Liver Disease (MASLD)

Ilaria Barchetta iD, Michele Zampieri, Flavia Agata Cimini, Sara Dule iD, Federica Sentinelli, Giulia Passarella, Alessandro Oldani, Katsiaryna Karpach, Maria Giulia Bacalini, Marco Giorgio Baroni iD, Anna Reale, Maria Gisella Cavallo iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26031271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ilaria Barchetta und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Liver Cirrhosis, Non-alcoholic Fatty Liver Disease, DNA Methylation, DNA Demethylation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sapienza University of Rome.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic-associated steatotic liver disease (MASLD) represents the most common chronic hepatopathy worldwide and an independent risk factor for cardiovascular disease and mortality, particularly when liver fibrosis occurs. Epigenetic alterations, such as DNA methylation, may influence MASLD susceptibility and progression; yet mechanisms underlying this process are limited. This study aimed to investigate whether active DNA demethylation in peripheral blood mononuclear cells (PBMCs) from individuals with MASLD, alongside the methylation and mRNA levels of inflammation- and fibrosis-related candidate genes, is associated with liver fibrosis. For this study, global demethylation intermediates (5-hydroxymethylcytosine [5hmC], 5-formylcytosine [5fC]) were quantified in PBMCs from 89 individuals with/without MASLD using ELISA. Site-specific DNA methylation of SOCS3, SREBF1, and TXNIP was analyzed by mass spectrometry-based bisulfite sequencing; mRNA expression was assessed via RT-PCR. Individuals with MASLD and moderate-to-high fibrosis risk (estimated by the fibrosis non-alcoholic steatohepatitis (NASH) index, FNI) progressively exhibited greater global 5hmC and 5fC levels. Higher FNI was associated with reduced methylation of the SOCS3 gene and increased mRNA expression of the SOCS3, TXNIP, IL-6, and MCP-1 genes. In conclusion, elevated fibrosis risk in MASLD is associated with active global DNA demethylation, as well as differential methylation and expression patterns of genes, which are key regulators of inflammation and fibrosis. These epigenetic alterations in PBMCs may mirror DNA methylation changes in the liver, which may potentially contribute to liver fibrogenesis and represent novel biomarkers for MASLD progression toward fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisNon-alcoholic Fatty Liver DiseaseDNA MethylationDNA DemethylationFatty LiverHumansMaleFemaleMiddle AgedSuppressor of Cytokine Signaling 3 ProteinLeukocytes, MononuclearAdultEpigenesis, GeneticCarrier ProteinsAged

Stichwörter der Autor:innen

DNA demethylationDNA methylationFNINASHepigeneticsfibrosis NASH indexliver fibrosismetabolic-associated fatty liver diseasenon-alcoholic fatty liver disease

Substanzen

Suppressor of Cytokine Signaling 3 ProteinSOCS3 protein, humanTXNIP protein, humanCarrier Proteins

Autor:innen und Institutionen

  • Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
  • Endocrinology and Diabetes, Department of Clinical Medicine, Public Health, Life and Environmental Sciences (MeSVA), University of L'Aquila, 67100 L'Aquila, Italy.
  • IRCCS Istituto delle Scienze Neurologiche di Bologna, 40139 Bologna, Italy.
  • Neuroendocrinology and Metabolic Diseases, IRCCS Neuromed, 86077 Pozzilli, Italy.

ORCID-Profile: Ilaria Barchetta, Sara Dule, Marco Giorgio Baroni, Maria Gisella Cavallo

Förderung

  • Sapienza University of Rome

Zitieren

APA

Barchetta, I., Zampieri, M., Cimini, F. A., Dule, S., Sentinelli, F., Passarella, G., Oldani, A., Karpach, K., Bacalini, M. G., Baroni, M. G., Reale, A., & Cavallo, M. G. (2025). Association Between Active DNA Demethylation and Liver Fibrosis in Individuals with Metabolic-Associated Steatotic Liver Disease (MASLD). International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031271

Vancouver

Barchetta I, Zampieri M, Cimini FA, Dule S, Sentinelli F, Passarella G, et al. Association Between Active DNA Demethylation and Liver Fibrosis in Individuals with Metabolic-Associated Steatotic Liver Disease (MASLD). International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031271

BibTeX
@article{Barchetta2025,
  author = {Barchetta, Ilaria and Zampieri, Michele and Cimini, Flavia Agata and Dule, Sara and Sentinelli, Federica and Passarella, Giulia and Oldani, Alessandro and Karpach, Katsiaryna and Bacalini, Maria Giulia and Baroni, Marco Giorgio and Reale, Anna and Cavallo, Maria Gisella},
  title = {Association Between Active DNA Demethylation and Liver Fibrosis in Individuals with Metabolic-Associated Steatotic Liver Disease (MASLD)},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26031271}
}
Kostenlos starten →